T. Rowe Price Associates
IDIX

T. Rowe Price Associates’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

T. Rowe Price Associates’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,404,444
Closed -$33.8M – 2605
2014
Q2 		$33.8M Sell
1,404,444
-6,817,349
-83% -$71.1M 0.01% 980
2014
Q1 		$49.6M Sell
8,221,793
-1,350,309
-14% -$9.42M 0.01% 866
2013
Q4 		$57.2M Sell
9,572,102
-1,433,750
-13% -$6.63M 0.01% 789
2013
Q3 		$57.3M Sell
11,005,852
-486,600
-4% -$2.13M 0.01% 769
2013
Q2 		$41.5M Buy
+11,492,452
New +$47M 0.01% 846

T. Rowe Price Associates's IDIX Position: Q3 2014 in Review

T. Rowe Price Associates sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 1,404,444 shares — an estimated $33.8M sold.

T. Rowe Price Associates first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $57.3M in Q3 2013. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • T. Rowe Price Associates reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • T. Rowe Price Associates sold 1,404,444 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $33.8M.
  • T. Rowe Price Associates first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • T. Rowe Price Associates's IDENIX PHARMACEUTICALS INC position peaked at $57.3M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on T. Rowe Price Associates's 13F filing for Q3 2014, filed 14 Nov 2014.